Finn, R., Clarke, C.A., Donohoe, W.T.A., McConnell, R.B., Sheppard, P.M., Lehane, D. and Kulke, W.: Experimental studies on the prevention of Rh-hemolytic disease. Brit. Med. J.1: 1486, 1961.
2.
Freda, V.J., Gorman, J.G. and Pollack, W.: Successful prevention of experimental Rh sensitization in man with an anti-Rh gamma2-globulin antibody preparation. Transfusion4: 26, 1964.
3.
Woodrow, J.C. , Clarke, C.A., Donohoe , W.T.A., Finn, R., McConnell, R.B., Sheppard, P.M., Lehane, D., Russell, S.H., Kulke, W. and Durkin, C.M.: Prevention of Rh-hemolytic disease: a third report. Brit. Med. J.1: 279, 1965.
4.
Kleihauer, E. , Braun, H. and Betke, K.: Demonstration von fetalem Hämoglobin in den Erytrocyten eines Blutausstrichs. Klin. Wschr.35: 637, 1957.
5.
Clarke, C.A. and Sheppard, P.M.: Prevention of Rhesus hemolytic disease . Lancet2: 343, 1965. 6. Freda, V.J., Gorman, J.G. and Pollack, W.: Rh factor: prevention of iso-immunization and clinical trial on mothers. Science151: 828, 1966.
—, Donohoe, W.T.A., McConnell, R.B., Woodrow , J.C., Finn, R., Krevans, J.R., Kulke, W., Lehane, D. and Sheppard, P.M.: Further experimental studies on the prevention of Rh-hemolytic disease. Ibid.1: 979, 1963.
8.
Anderson, J.M. and Benirschke, K.: Maternal tolerance of foetal tissue . Ibid.1: 1534, 1964.